Skip to main content

Accanto Health Names Jay Campbell Chief Executive Officer

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

Accanto Health, the parent company of The Emily Program, today announced the appointment of Jay Campbell as Chief Executive Officer. Campbell, who previously served as President, will lead company strategy and operations, with a continued focus on expanding awareness of The Emily Program, increasing access to its high-quality eating disorder care nationwide, and strengthening the systems that support clinicians and staff delivering compassionate, evidence-based eating disorder care.

Campbell brings more than 25 years of leadership experience in healthcare, including 15 years in behavioral health, with a track record of building high-performing teams and guiding complex organizations through growth and transformation.

“We are pleased to appoint Jay as Chief Executive Officer of The Emily Program,” said Dirk Miller, Founder of The Emily Program, Executive Chair of the Board of Directors and Leader of the Clinical Advisory Council for Accanto Health. “Jay is a proven leader with deep experience in behavioral health organizations and a clear understanding of how to scale operations while maintaining a strong commitment to clinical excellence. We are confident in his ability to guide the organization’s continued growth and delivery of care.”

Campbell succeeds Jessie Morsching as Chief Executive Officer of Accanto Health. Morsching has departed the organization.

“We are grateful to Jessie for her leadership and contributions to Accanto Health and The Emily Program,” added Miller. “During her tenure, Jessie provided steady and thoughtful leadership, strengthening the organization’s foundation, and supporting teams through a period of transition. We thank her for her commitment to our mission and her focus on keeping excellent client care at the center of our work.”

Campbell joined Accanto Health and The Emily Program from Newport Healthcare, where he served as Chief Growth Officer for nearly seven years. Previously, he held senior leadership roles at Acadia Healthcare as Vice President of Business Development and Business Relations, and at CRC Health Group where he led business development and growth initiatives supporting national expansion and increasing organizational scale.

“I am honored to step into the CEO role at Accanto Health and The Emily Program and build on the strong foundation established by the team,” said Campbell. “Eating disorders affect millions of individuals and families across the country, and meeting that need requires clinical excellence and coordinated systems that make care accessible, consistent, and effective at scale. I am focused on ensuring we continue to set the industry standard for delivering advanced treatment capabilities, highly trained clinicians, and high-quality end-to-end care.”

Campbell received his Bachelor of Arts in Biology from Hartwick College.

About The Emily Program

The Emily Program is nationally recognized for its compassionate and evidence-based approach to eating disorder treatment. With locations across the country and robust virtual care options, The Emily Program provides accessible, expert care that addresses the physical, emotional, and social aspects of recovery. For more information about The Emily Program’s services, visit www.emilyprogram.com or call 1-888-272-0845.

"I am focused on ensuring we continue to set the industry standard for delivering advanced treatment capabilities, highly trained clinicians, and high-quality end-to-end care.” - Jay Campbell

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  266.43
+10.17 (3.97%)
AAPL  319.70
+5.12 (1.63%)
AMD  465.58
-11.09 (-2.33%)
BAC  62.32
+1.15 (1.88%)
GOOG  342.88
+5.17 (1.53%)
META  578.02
+6.92 (1.21%)
MSFT  513.53
+8.47 (1.68%)
NVDA  217.55
-10.43 (-4.57%)
ORCL  150.85
-1.09 (-0.72%)
TSLA  348.75
-6.06 (-1.71%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.